113 related articles for article (PubMed ID: 15901937)
1. Immunohistochemical detection of ornithine decarboxylase as a measure of chemosensitivity testing.
Bachrach U
Methods Mol Med; 2005; 110():197-211. PubMed ID: 15901937
[TBL] [Abstract][Full Text] [Related]
2. In vitro chemosensitivity testing of hematological cancer patients: detection of ornithine decarboxylase.
Bachrach U; Wang Y
Recent Results Cancer Res; 2003; 161():62-70. PubMed ID: 12528799
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells.
Hsu PC; Hung HC; Liao YF; Liu CC; Tsay GJ; Liu GY
Leuk Res; 2008 Oct; 32(10):1530-40. PubMed ID: 18339422
[TBL] [Abstract][Full Text] [Related]
4. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
5. Polyamines and cancer: minireview article.
Bachrach U
Amino Acids; 2004 Jul; 26(4):307-9. PubMed ID: 15290334
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitivity and chemoresistance testing in ovarian cancer.
Cree IA
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):39-43. PubMed ID: 19125002
[TBL] [Abstract][Full Text] [Related]
7. Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus.
Li W; Liu X; Wang W; Sun H; Hu Y; Lei H; Liu G; Gao Y
Prostate; 2008 Sep; 68(12):1354-61. PubMed ID: 18548481
[TBL] [Abstract][Full Text] [Related]
8. An overview of chemosensitivity testing.
Blumenthal RD
Methods Mol Med; 2005; 110():3-18. PubMed ID: 15901922
[TBL] [Abstract][Full Text] [Related]
9. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
10. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
11. [Theory and actual attempts to establish an effective cancer chemotherapy].
Fujimoto S
Gan To Kagaku Ryoho; 1997 Feb; 24(4):501-10. PubMed ID: 9063491
[TBL] [Abstract][Full Text] [Related]
12. [Chemosensitivity test on brain tumors].
Gil-Salú JL; Bosco-López J; Domi Nguez-Villar M; Domínguez-Pascual I; Pérez-Requena J; Palomo MJ; López-Escobar M
Neurocirugia (Astur); 2008 Feb; 19(1):5-11. PubMed ID: 18335150
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of ODC and AdoMetDC bi-antisense virus on the growth and invasion of lung cancer cell A-549].
Sun DF; Tian H; Liu XX; Zhang B; Zhang Y; Sun QF
Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(1):61-4. PubMed ID: 18510008
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity.
Itaya M; Yoshimoto J; Kojima K; Kawasaki S
Methods Mol Med; 2005; 110():213-27. PubMed ID: 15901938
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
16. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
[TBL] [Abstract][Full Text] [Related]
17. N-ω-chloroacetyl-l-ornithine, a new competitive inhibitor of ornithine decarboxylase, induces selective growth inhibition and cytotoxicity on human cancer cells versus normal cells.
Medina-Enríquez MM; Alcántara-Farfán V; Aguilar-Faisal L; Trujillo-Ferrara JG; Rodríguez-Páez L; Vargas-Ramírez AL
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):345-53. PubMed ID: 24939101
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Voltattorni M; Zini M; Stefanelli C; Masotti L; Shoemaker RH
J Med Chem; 2008 Dec; 51(23):7508-13. PubMed ID: 19006285
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of ornithine decarboxylase in individual cells: potential application for in vitro chemosensitivity assays.
Shayovits A; Bachrach U
J Histochem Cytochem; 1994 May; 42(5):607-11. PubMed ID: 8157932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
